Details for New Drug Application (NDA): 021742

✉ Email this page to a colleague

NDA 021742 describes BYSTOLIC, which is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. Additional details are available on the BYSTOLIC profile page.

The generic ingredient in BYSTOLIC is nebivolol hydrochloride. There are fourteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the nebivolol hydrochloride profile page.

Summary for 021742

Tradename:	BYSTOLIC
Applicant:	Allergan
Ingredient:	nebivolol hydrochloride
Patents:	0

Pharmacology for NDA: 021742

Mechanism of Action	Adrenergic beta-Antagonists

Medical Subject Heading (MeSH) Categories for 021742

Adrenergic beta-1 Receptor Agonists
Antihypertensive Agents
Vasodilator Agents

Suppliers and Packaging for NDA: 021742

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
BYSTOLIC	nebivolol hydrochloride	TABLET;ORAL	021742	NDA	Allergan, Inc.	0456-1402	0456-1402-01	100 TABLET in 1 BOTTLE (0456-1402-01)
BYSTOLIC	nebivolol hydrochloride	TABLET;ORAL	021742	NDA	Allergan, Inc.	0456-1402	0456-1402-30	30 TABLET in 1 BOTTLE (0456-1402-30)

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 2.5MG BASE
Approval Date:	Dec 17, 2007	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 5MG BASE
Approval Date:	Dec 17, 2007	TE:	AB	RLD:	Yes

Profile for product number 004

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 10MG BASE
Approval Date:	Dec 17, 2007	TE:	AB	RLD:	Yes

Expired US Patents for NDA 021742

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	BYSTOLIC	nebivolol hydrochloride	TABLET;ORAL	021742-004	Dec 17, 2007	⤷ Subscribe	⤷ Subscribe
Allergan	BYSTOLIC	nebivolol hydrochloride	TABLET;ORAL	021742-002	Dec 17, 2007	⤷ Subscribe	⤷ Subscribe
Allergan	BYSTOLIC	nebivolol hydrochloride	TABLET;ORAL	021742-005	Oct 8, 2008	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.